Bolt Biotherapeutics (BOLT) Other Accumulated Expenses (2020 - 2026)
Bolt Biotherapeutics (BOLT) reported Other Accumulated Expenses of $563,000 for Q2 2026, up 12.6% from $500,000 a year earlier and up 37.3% from the prior quarter.
Powered by 
Analysis
Bolt Biotherapeutics (BOLT) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Bolt Biotherapeutics posted Other Accumulated Expenses of $288,000, down 24.2% from FY2024.
- Other Accumulated Expenses has declined for four consecutive years, with a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $380,000 in FY2024 (-33.8%), $574,000 in FY2023 (-40.4%), $963,000 in FY2022 (-19.6%) and $1.2 million in FY2021 (+106.9%).
- The Q2 2026 figure ranks as the highest quarterly Other Accumulated Expenses since Q1 2024.
- Year over year, Other Accumulated Expenses gained in three of the last eight quarters, with an average decline of 17.9%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q1 2022 (growth of 140.5%); the low point was Q3 2024 (a decline of 56.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $410,000 (Q1 2026), $288,000 (Q4 2025) and $385,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Bolt Biotherapeutics | 6.65 Mn | 6.65 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 563,000.00 |
| Mar 31, 2026 | 410,000.00 |
| Dec 31, 2025 | 288,000.00 |
| Sep 30, 2025 | 385,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 526,000.00 |
| Dec 31, 2024 | 380,000.00 |
| Sep 30, 2024 | 373,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | 813,000.00 |
| Dec 31, 2023 | 574,000.00 |
| Sep 30, 2023 | 849,000.00 |
| Jun 30, 2023 | 826,000.00 |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 963,000.00 |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 906,000.00 |
| Mar 31, 2022 | 1.96 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 837,000.00 |
API Access
Bolt Biotherapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();